PI
ELDN icon

Putnam Investments’s Eledon Pharmaceuticals ELDN Stock Holding History

Putnam Investments’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-619
Closed -$553K – 1284
2016
Q2 		$553K Sell
619
-1
-0.2% -$1.1K ﹤0.01% 1182
2016
Q1 		$563K Buy
620
+1
+0.2% +$982 ﹤0.01% 1225
2015
Q4 		$874K Buy
619
+202
+48% +$352K ﹤0.01% 1186
2015
Q3 		$699K Hold
417
– – ﹤0.01% 1253
2015
Q2 		$898K Hold
417
– – ﹤0.01% 1243
2015
Q1 		$763K Hold
417
– – ﹤0.01% 1247
2014
Q4 		$995K Hold
417
– – ﹤0.01% 1177
2014
Q3 		$1.02M Buy
+417
New +$1.19M ﹤0.01% 1205

Other funds holding ELDN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments's ELDN Position: Q3 2016 in Review

Putnam Investments sold out of Eledon Pharmaceuticals (ELDN) in Q3 2016, closing a stake of 619 shares — an estimated $553K sold.

Putnam Investments first reported a position in ELDN in Q3 2014 and held it in 8 quarters. The position peaked at $1.02M in Q3 2014. 44 funds tracked by Wall St. Rank hold ELDN as of Q3 2016.

  • Putnam Investments reported no remaining Eledon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Putnam Investments sold 619 Eledon Pharmaceuticals shares in Q3 2016, an estimated $553K.
  • Putnam Investments first reported a position in Eledon Pharmaceuticals in Q3 2014 and held it in 8 quarters.
  • Putnam Investments's Eledon Pharmaceuticals position peaked at $1.02M in Q3 2014.
  • 44 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2016.

Based on Putnam Investments's 13F filing for Q3 2016, filed 14 Nov 2016.